BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31733200)

  • 41. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension.
    Biasin V; Marsh LM; Egemnazarov B; Wilhelm J; Ghanim B; Klepetko W; Wygrecka M; Olschewski H; Eferl R; Olschewski A; Kwapiszewska G
    J Pathol; 2014 May; 233(1):7-17. PubMed ID: 24258247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels.
    Jiang Y; Zhou Y; Peng G; Liu N; Tian H; Pan D; Liu L; Yang X; Li C; Li W; Chen L; Ran P; Dai A
    Int J Biochem Cell Biol; 2018 Nov; 104():161-170. PubMed ID: 30266526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27.
    Li XW; Hu CP; Wu WH; Zhang WF; Zou XZ; Li YJ
    Eur J Pharmacol; 2012 Mar; 679(1-3):117-26. PubMed ID: 22306243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
    Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
    Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica.
    Zelko IN; Zhu J; Ritzenthaler JD; Roman J
    Respir Res; 2016 Nov; 17(1):160. PubMed ID: 27894297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
    Zhang Y; Peng B; Han Y
    Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells.
    Jiang Y; Huang J; Xia Y; Sun Z; Hu P; Wang D; Liu Y; Tao T; Liu Y
    Eur J Pharmacol; 2023 Feb; 941():175502. PubMed ID: 36638952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circular RNA Calm4 Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cells Pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 Axis.
    Jiang Y; Liu H; Yu H; Zhou Y; Zhang J; Xin W; Li Y; He S; Ma C; Zheng X; Zhang L; Zhao X; Wu B; Jiang C; Zhu D
    Arterioscler Thromb Vasc Biol; 2021 May; 41(5):1675-1693. PubMed ID: 33657879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1α-KV1.5 channel pathway.
    He Y; Fang X; Shi J; Li X; Xie M; Liu X
    Chem Biol Interact; 2020 Feb; 317():108942. PubMed ID: 31930969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of cullin7 promotes proliferation and migration of pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension.
    Liu H; Ge XY; Huang N; Liu T; Yao MZ; Zhang Z; Qian ZX; Hu CP
    Eur J Pharmacol; 2019 Dec; 864():172698. PubMed ID: 31563647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
    Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
    Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of SRF Is Associated With Hypoxic Pulmonary Hypertension by Promoting Viability of Smooth Muscle Cells via Increasing Expression of Bcl-2.
    Ding X; Zhou S; Li M; Cao C; Wu P; Sun L; Fei G; Wang R
    J Cell Biochem; 2017 Sep; 118(9):2731-2738. PubMed ID: 28176371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2.
    Liu H; Tao Y; Chen M; Yu J; Li WJ; Tao L; Li Y; Li F
    Sci Rep; 2016 Jul; 6():24661. PubMed ID: 27381447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy.
    Zhang X; Liu Q; Zhang C; Sheng J; Li S; Li W; Yang X; Wang X; He S; Bai J; Zhu D
    J Pharmacol Sci; 2019 Oct; 141(2):97-105. PubMed ID: 31640920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia.
    Wei L; Zhang B; Cao W; Xing H; Yu X; Zhu D
    J Recept Signal Transduct Res; 2015; 35(4):329-39. PubMed ID: 25421526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.